ANTI-THYMOCYTE GLOBULIN (ATG) COULD IMPROVE THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE T CELL TUMORS

被引：0
|
作者：
Chun, W. [1 ]
Shike, Y. [1 ]
Liping, W. [1 ]
Jieling, J. [1 ]
Yu, C. [1 ]
Jun, Y. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Div Hematol, Shanghai 200030, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P011
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] ANTI-THYMOCYTE GLOBULIN (ATG) COULD IMPROVE THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE T CELL TUMORS
    Juan, Y.
    Chun, W.
    Jieling, J.
    Iiping, W.
    Yu, C.
    Shike, Y.
    HAEMATOLOGICA, 2014, 99 : 431 - 431
  • [2] Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors
    Yang, J.
    Cai, Y.
    Jiang, J. L.
    Wan, L. P.
    Yan, S. K.
    Wang, C.
    BLOOD CANCER JOURNAL, 2015, 5 : e332 - e332
  • [3] Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors
    J Yang
    Y Cai
    J L Jiang
    L P Wan
    S K Yan
    C Wang
    Blood Cancer Journal, 2015, 5 : e332 - e332
  • [4] Anti-thymocyte globulin(ATG) could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory peripheral T-cell lymphoma
    Jun, Y.
    Chun, W.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5624 - 5624
  • [5] Different Doses of Anti-Thymocyte Globulin (ATG) in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation
    Pekcan, G.
    Atesagaoglu, B.
    Merter, M.
    Topcuoglu, P.
    Bozdag, S. Civriz
    Toprak, S. K.
    Yuksel, M. Kurt
    Ates, O.
    Ozcan, M.
    Demirer, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S228 - S229
  • [6] Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
    Baron, Frederic
    Galimard, Jacques-Emmanue
    Labopin, Myriam
    Yakoub-Agha, Ibrahim
    Niittyvuopio, Riitta
    Kroeger, Nicolaus
    Griskevicius, Laimonas
    Wu, Depei
    Forcade, Edouard
    Richard, Carlos
    Aljurf, Mahmoud
    Helbig, Grzegorz
    Labussiere-Wallet, Helene
    Mohty, Mohamad
    Nagler, Arnon
    HAEMATOLOGICA, 2020, 105 (04) : 1138 - 1146
  • [7] Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
    Park, Bo-Kyoung
    Kim, Hyo-Sup
    Kim, Seongkoo
    Lee, Jae-Wook
    Park, Young Shil
    Jang, Pil-Sang
    Chung, Nack-Gyun
    Jeong, Dae-Chul
    Cho, Bin
    BLOOD RESEARCH, 2018, 53 (02) : 145 - 151
  • [8] Enhanced hepatic toxicity in patients with myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation and anti-thymocyte globulin treatment
    Ecsedi, M.
    Halter, J.
    Heim, M.
    Passweg, J.
    Lengerke, C.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S74 - S74
  • [9] Analysis of Anti-thymocyte Globulin (Atg) Infusion-related Fever in the Allogeneic Hematopoietic Stem Cell Transplantation (Allo-hsct) Setting
    Pizarro, M. J.
    Aguirre, L.
    Echevarria, N.
    Caminos, N.
    Artola, M. T.
    Ferreiro, J. J.
    Araiz, M.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S239 - S239
  • [10] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
    Ecsedi, Matyas
    Schmohl, Joerg
    Zeiser, Robert
    Drexler, Beatrice
    Halter, Jorg
    Medinger, Michael
    Duyster, Justus
    Kanz, Lothar
    Passweg, Jakob
    Finke, Juergen
    Bethge, Wolfgang
    Lengerke, Claudia
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1627 - 1636
12345